158 related articles for article (PubMed ID: 12908033)
21. Relationship between schistosomicidal drug efficacy, gonadal steroid hormonal changes and state of disease immunopathology in murine schistosomiasis mansoni.
Botros SS; Salama SH; Estafan MY; Gomaa NE; Metwally AA; Ebeid FA
Pharmacol Res; 1990; 22(3):359-70. PubMed ID: 2114615
[TBL] [Abstract][Full Text] [Related]
22. Activity of oxamniquine at skin, pulmonary and sexual maturation phases, on a Schistosoma mansoni strain (R1) previously reported as resistant at the adult phase.
Coelho PM; Ribeiro F; Mello RT; Lima e Silva FC; Nogueira-Machado JA
Mem Inst Oswaldo Cruz; 1998; 93 Suppl 1():267-8. PubMed ID: 9921366
[No Abstract] [Full Text] [Related]
23. Isothermal microcalorimetry to study drugs against Schistosoma mansoni.
Manneck T; Braissant O; Haggenmüller Y; Keiser J
J Clin Microbiol; 2011 Apr; 49(4):1217-25. PubMed ID: 21270220
[TBL] [Abstract][Full Text] [Related]
24. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
Fallon PG; Doenhoff MJ
Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
[TBL] [Abstract][Full Text] [Related]
25. A novel cell-free method to culture Schistosoma mansoni from cercariae to juvenile worm stages for in vitro drug testing.
Frahm S; Anisuzzaman A; Prodjinotho UF; Vejzagić N; Verschoor A; Prazeres da Costa C
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006590. PubMed ID: 30689639
[TBL] [Abstract][Full Text] [Related]
26. Assessment of tegumental damage to Schistosoma mansoni and S. haematobium after in vitro exposure to ferrocenyl, ruthenocenyl and benzyl derivatives of oxamniquine using scanning electron microscopy.
Buchter V; Hess J; Gasser G; Keiser J
Parasit Vectors; 2018 Nov; 11(1):580. PubMed ID: 30400935
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
[TBL] [Abstract][Full Text] [Related]
28. Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure.
Sabra AN; Botros SS
J Parasitol; 2008 Apr; 94(2):537-41. PubMed ID: 18564758
[TBL] [Abstract][Full Text] [Related]
29. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M
Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384
[TBL] [Abstract][Full Text] [Related]
30. Praziquantel--its use, cost and possible development of resistance.
Kusel J; Hagan P
Parasitol Today; 1999 Sep; 15(9):352-4. PubMed ID: 10461159
[No Abstract] [Full Text] [Related]
31. Genetic analysis of praziquantel resistance in Schistosoma mansoni.
Liang YS; Dai JR; Zhu YC; Coles GC; Doenhoff MJ
Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):274-80. PubMed ID: 12971549
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of alternating therapy with oxamniquine and praziquantel to treat Schistosoma mansoni in children following failure of first treatment.
Katz N; Rocha RS; de Souza CP; Coura Filho P; Bruce JI; Coles GC; Kinoti GK
Am J Trop Med Hyg; 1991 May; 44(5):509-12. PubMed ID: 1905880
[TBL] [Abstract][Full Text] [Related]
33. THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL.
Mendonça AM; Feitosa AP; Veras DL; Matos-Rocha TJ; Cavalcanti MG; Barbosa CC; Brayner FA; Alves LC
Rev Inst Med Trop Sao Paulo; 2016; 58():7. PubMed ID: 26910445
[TBL] [Abstract][Full Text] [Related]
34. The association of steroids and schistosomicides in the treatment of experimental schistosomiasis.
Lambertucci JR; Modha J; Curtis R; Doenhoff M
Trans R Soc Trop Med Hyg; 1989; 83(3):354-7. PubMed ID: 2515622
[TBL] [Abstract][Full Text] [Related]
35. Early Antischistosomal Leads Identified from in Vitro and in Vivo Screening of the Medicines for Malaria Venture Pathogen Box.
Pasche V; Laleu B; Keiser J
ACS Infect Dis; 2019 Jan; 5(1):102-110. PubMed ID: 30398059
[TBL] [Abstract][Full Text] [Related]
36. [Effect of chemotherapy on the Schistosoma mansoni eggs].
dos Reis MG; Andrade ZA
Mem Inst Oswaldo Cruz; 1987; 82(2):161-5. PubMed ID: 3147355
[TBL] [Abstract][Full Text] [Related]
37. Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails.
Couto FF; Coelho PM; Araújo N; Kusel JR; Katz N; Jannotti-Passos LK; Mattos AC
Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):153-7. PubMed ID: 21537673
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a method for induction of praziquantel resistance in Schistosoma mansoni.
Lotfy WM; Hishmat MG; El Nashar AS; Abu El Einin HM
Pharm Biol; 2015 Aug; 53(8):1214-9. PubMed ID: 25609146
[TBL] [Abstract][Full Text] [Related]
39. Scanning electron microscopy of the tegumental surface of in vivo treated Schistosoma mansoni (Saudi Arabian geographical strain) with oxamniquine and praziquantel.
Shalaby IM; Banaja AA; Ghandour AM
J Egypt Soc Parasitol; 1991 Dec; 21(3):797-810. PubMed ID: 1765693
[TBL] [Abstract][Full Text] [Related]
40. Anti-schistosomal drugs: observations on the mechanism of drug resistance to hycanthone, and on the involvement of host antibodies in the mode of action of praziquantel.
Brindley PJ; Sher A
Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():157-61. PubMed ID: 3151089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
